世界のオピオイド使用障害市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Opioid Use Disorder Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4617
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、オピオイド使用障害の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ブプレノルフィン、メタドン、ナルトレキソン）、用途別市場規模（中等度疼痛治療、重度疼痛治療）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・オピオイド使用障害の市場動向
・企業の競争状況、市場シェア
・オピオイド使用障害の種類別市場規模と予測2016-2027（ブプレノルフィン、メタドン、ナルトレキソン）
・オピオイド使用障害の用途別市場規模と予測2016-2027（中等度疼痛治療、重度疼痛治療）
・オピオイド使用障害の北米市場規模2016-2027（アメリカ、カナダ）
・オピオイド使用障害の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・オピオイド使用障害のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・オピオイド使用障害の中南米市場規模2016-2027（メキシコ、ブラジル）
・オピオイド使用障害の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Indivior、Alkermes、Titan Pharmaceuticals、Hikma Pharmaceuticals、Teva Pharmaceuticals、MediciNova、Orexo、Camurus、Omeros）
・結論

An opioid is a synthetic or natural agent that stimulates opioid receptors and produces opium-like effects. Opioid use disorder is a problematic pattern of opioid use that causes significant impairment or distress.
Increase in opioid epidemic in the U.S. coupled with establishment of government policies to control the crisis is driving the market.

Market Analysis and Insights: Global Opioid Use Disorder Market
The global Opioid Use Disorder market size is projected to reach US$ 2660 million by 2027, from US$ 1747.7 million in 2020, at a CAGR of 5.7% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Opioid Use Disorder market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Opioid Use Disorder market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Opioid Use Disorder market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Opioid Use Disorder market.

Global Opioid Use Disorder Scope and Market Size
Opioid Use Disorder market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Opioid Use Disorder market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Buprenorphine
Methadone
Naltrexone

Segment by Application
Moderate Pain Treatment
Severe Pain Treatment

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Indivior
Alkermes
Titan Pharmaceuticals
Hikma Pharmaceuticals
Teva Pharmaceuticals
MediciNova
Orexo
Camurus
Omeros

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Opioid Use Disorder Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Buprenorphine
1.2.3 Methadone
1.2.4 Naltrexone
1.3 Market by Application
1.3.1 Global Opioid Use Disorder Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Moderate Pain Treatment
1.3.3 Severe Pain Treatment
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Opioid Use Disorder Market Perspective (2016-2027)
2.2 Opioid Use Disorder Growth Trends by Regions
2.2.1 Opioid Use Disorder Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Opioid Use Disorder Historic Market Share by Regions (2016-2021)
2.2.3 Opioid Use Disorder Forecasted Market Size by Regions (2022-2027)
2.3 Opioid Use Disorder Industry Dynamic
2.3.1 Opioid Use Disorder Market Trends
2.3.2 Opioid Use Disorder Market Drivers
2.3.3 Opioid Use Disorder Market Challenges
2.3.4 Opioid Use Disorder Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Opioid Use Disorder Players by Revenue
3.1.1 Global Top Opioid Use Disorder Players by Revenue (2016-2021)
3.1.2 Global Opioid Use Disorder Revenue Market Share by Players (2016-2021)
3.2 Global Opioid Use Disorder Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Opioid Use Disorder Revenue
3.4 Global Opioid Use Disorder Market Concentration Ratio
3.4.1 Global Opioid Use Disorder Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Opioid Use Disorder Revenue in 2020
3.5 Opioid Use Disorder Key Players Head office and Area Served
3.6 Key Players Opioid Use Disorder Product Solution and Service
3.7 Date of Enter into Opioid Use Disorder Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Opioid Use Disorder Breakdown Data by Type
4.1 Global Opioid Use Disorder Historic Market Size by Type (2016-2021)
4.2 Global Opioid Use Disorder Forecasted Market Size by Type (2022-2027)

5 Opioid Use Disorder Breakdown Data by Application
5.1 Global Opioid Use Disorder Historic Market Size by Application (2016-2021)
5.2 Global Opioid Use Disorder Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Opioid Use Disorder Market Size (2016-2027)
6.2 North America Opioid Use Disorder Market Size by Type
6.2.1 North America Opioid Use Disorder Market Size by Type (2016-2021)
6.2.2 North America Opioid Use Disorder Market Size by Type (2022-2027)
6.2.3 North America Opioid Use Disorder Market Size by Type (2016-2027)
6.3 North America Opioid Use Disorder Market Size by Application
6.3.1 North America Opioid Use Disorder Market Size by Application (2016-2021)
6.3.2 North America Opioid Use Disorder Market Size by Application (2022-2027)
6.3.3 North America Opioid Use Disorder Market Size by Application (2016-2027)
6.4 North America Opioid Use Disorder Market Size by Country
6.4.1 North America Opioid Use Disorder Market Size by Country (2016-2021)
6.4.2 North America Opioid Use Disorder Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Opioid Use Disorder Market Size (2016-2027)
7.2 Europe Opioid Use Disorder Market Size by Type
7.2.1 Europe Opioid Use Disorder Market Size by Type (2016-2021)
7.2.2 Europe Opioid Use Disorder Market Size by Type (2022-2027)
7.2.3 Europe Opioid Use Disorder Market Size by Type (2016-2027)
7.3 Europe Opioid Use Disorder Market Size by Application
7.3.1 Europe Opioid Use Disorder Market Size by Application (2016-2021)
7.3.2 Europe Opioid Use Disorder Market Size by Application (2022-2027)
7.3.3 Europe Opioid Use Disorder Market Size by Application (2016-2027)
7.4 Europe Opioid Use Disorder Market Size by Country
7.4.1 Europe Opioid Use Disorder Market Size by Country (2016-2021)
7.4.2 Europe Opioid Use Disorder Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Opioid Use Disorder Market Size (2016-2027)
8.2 Asia-Pacific Opioid Use Disorder Market Size by Type
8.2.1 Asia-Pacific Opioid Use Disorder Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Opioid Use Disorder Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Opioid Use Disorder Market Size by Type (2016-2027)
8.3 Asia-Pacific Opioid Use Disorder Market Size by Application
8.3.1 Asia-Pacific Opioid Use Disorder Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Opioid Use Disorder Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Opioid Use Disorder Market Size by Application (2016-2027)
8.4 Asia-Pacific Opioid Use Disorder Market Size by Region
8.4.1 Asia-Pacific Opioid Use Disorder Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Opioid Use Disorder Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Opioid Use Disorder Market Size (2016-2027)
9.2 Latin America Opioid Use Disorder Market Size by Type
9.2.1 Latin America Opioid Use Disorder Market Size by Type (2016-2021)
9.2.2 Latin America Opioid Use Disorder Market Size by Type (2022-2027)
9.2.3 Latin America Opioid Use Disorder Market Size by Type (2016-2027)
9.3 Latin America Opioid Use Disorder Market Size by Application
9.3.1 Latin America Opioid Use Disorder Market Size by Application (2016-2021)
9.3.2 Latin America Opioid Use Disorder Market Size by Application (2022-2027)
9.3.3 Latin America Opioid Use Disorder Market Size by Application (2016-2027)
9.4 Latin America Opioid Use Disorder Market Size by Country
9.4.1 Latin America Opioid Use Disorder Market Size by Country (2016-2021)
9.4.2 Latin America Opioid Use Disorder Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Opioid Use Disorder Market Size (2016-2027)
10.2 Middle East & Africa Opioid Use Disorder Market Size by Type
10.2.1 Middle East & Africa Opioid Use Disorder Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Opioid Use Disorder Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Opioid Use Disorder Market Size by Type (2016-2027)
10.3 Middle East & Africa Opioid Use Disorder Market Size by Application
10.3.1 Middle East & Africa Opioid Use Disorder Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Opioid Use Disorder Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Opioid Use Disorder Market Size by Application (2016-2027)
10.4 Middle East & Africa Opioid Use Disorder Market Size by Country
10.4.1 Middle East & Africa Opioid Use Disorder Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Opioid Use Disorder Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Indivior
11.1.1 Indivior Company Details
11.1.2 Indivior Business Overview
11.1.3 Indivior Opioid Use Disorder Introduction
11.1.4 Indivior Revenue in Opioid Use Disorder Business (2016-2021)
11.1.5 Indivior Recent Development
11.2 Alkermes
11.2.1 Alkermes Company Details
11.2.2 Alkermes Business Overview
11.2.3 Alkermes Opioid Use Disorder Introduction
11.2.4 Alkermes Revenue in Opioid Use Disorder Business (2016-2021)
11.2.5 Alkermes Recent Development
11.3 Titan Pharmaceuticals
11.3.1 Titan Pharmaceuticals Company Details
11.3.2 Titan Pharmaceuticals Business Overview
11.3.3 Titan Pharmaceuticals Opioid Use Disorder Introduction
11.3.4 Titan Pharmaceuticals Revenue in Opioid Use Disorder Business (2016-2021)
11.3.5 Titan Pharmaceuticals Recent Development
11.4 Hikma Pharmaceuticals
11.4.1 Hikma Pharmaceuticals Company Details
11.4.2 Hikma Pharmaceuticals Business Overview
11.4.3 Hikma Pharmaceuticals Opioid Use Disorder Introduction
11.4.4 Hikma Pharmaceuticals Revenue in Opioid Use Disorder Business (2016-2021)
11.4.5 Hikma Pharmaceuticals Recent Development
11.5 Teva Pharmaceuticals
11.5.1 Teva Pharmaceuticals Company Details
11.5.2 Teva Pharmaceuticals Business Overview
11.5.3 Teva Pharmaceuticals Opioid Use Disorder Introduction
11.5.4 Teva Pharmaceuticals Revenue in Opioid Use Disorder Business (2016-2021)
11.5.5 Teva Pharmaceuticals Recent Development
11.6 MediciNova
11.6.1 MediciNova Company Details
11.6.2 MediciNova Business Overview
11.6.3 MediciNova Opioid Use Disorder Introduction
11.6.4 MediciNova Revenue in Opioid Use Disorder Business (2016-2021)
11.6.5 MediciNova Recent Development
11.7 Orexo
11.7.1 Orexo Company Details
11.7.2 Orexo Business Overview
11.7.3 Orexo Opioid Use Disorder Introduction
11.7.4 Orexo Revenue in Opioid Use Disorder Business (2016-2021)
11.7.5 Orexo Recent Development
11.8 Camurus
11.8.1 Camurus Company Details
11.8.2 Camurus Business Overview
11.8.3 Camurus Opioid Use Disorder Introduction
11.8.4 Camurus Revenue in Opioid Use Disorder Business (2016-2021)
11.8.5 Camurus Recent Development
11.9 Omeros
11.9.1 Omeros Company Details
11.9.2 Omeros Business Overview
11.9.3 Omeros Opioid Use Disorder Introduction
11.9.4 Omeros Revenue in Opioid Use Disorder Business (2016-2021)
11.9.5 Omeros Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Opioid Use Disorder Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Buprenorphine
Table 3. Key Players of Methadone
Table 4. Key Players of Naltrexone
Table 5. Global Opioid Use Disorder Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Opioid Use Disorder Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Opioid Use Disorder Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Opioid Use Disorder Market Share by Regions (2016-2021)
Table 9. Global Opioid Use Disorder Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Opioid Use Disorder Market Share by Regions (2022-2027)
Table 11. Opioid Use Disorder Market Trends
Table 12. Opioid Use Disorder Market Drivers
Table 13. Opioid Use Disorder Market Challenges
Table 14. Opioid Use Disorder Market Restraints
Table 15. Global Opioid Use Disorder Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Opioid Use Disorder Market Share by Players (2016-2021)
Table 17. Global Top Opioid Use Disorder Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid Use Disorder as of 2020)
Table 18. Ranking of Global Top Opioid Use Disorder Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Opioid Use Disorder Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Opioid Use Disorder Product Solution and Service
Table 22. Date of Enter into Opioid Use Disorder Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Opioid Use Disorder Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Opioid Use Disorder Revenue Market Share by Type (2016-2021)
Table 26. Global Opioid Use Disorder Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Opioid Use Disorder Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Opioid Use Disorder Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Opioid Use Disorder Revenue Market Share by Application (2016-2021)
Table 30. Global Opioid Use Disorder Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Opioid Use Disorder Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Opioid Use Disorder Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Opioid Use Disorder Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Opioid Use Disorder Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Opioid Use Disorder Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Opioid Use Disorder Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Opioid Use Disorder Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Opioid Use Disorder Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Opioid Use Disorder Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Opioid Use Disorder Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Opioid Use Disorder Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Opioid Use Disorder Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Opioid Use Disorder Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Opioid Use Disorder Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Opioid Use Disorder Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Opioid Use Disorder Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Opioid Use Disorder Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Opioid Use Disorder Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Opioid Use Disorder Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Opioid Use Disorder Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Opioid Use Disorder Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Opioid Use Disorder Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Opioid Use Disorder Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Opioid Use Disorder Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Opioid Use Disorder Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Opioid Use Disorder Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Opioid Use Disorder Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Opioid Use Disorder Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Opioid Use Disorder Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Opioid Use Disorder Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Opioid Use Disorder Market Size by Country (2022-2027) & (US$ Million)
Table 62. Indivior Company Details
Table 63. Indivior Business Overview
Table 64. Indivior Opioid Use Disorder Product
Table 65. Indivior Revenue in Opioid Use Disorder Business (2016-2021) & (US$ Million)
Table 66. Indivior Recent Development
Table 67. Alkermes Company Details
Table 68. Alkermes Business Overview
Table 69. Alkermes Opioid Use Disorder Product
Table 70. Alkermes Revenue in Opioid Use Disorder Business (2016-2021) & (US$ Million)
Table 71. Alkermes Recent Development
Table 72. Titan Pharmaceuticals Company Details
Table 73. Titan Pharmaceuticals Business Overview
Table 74. Titan Pharmaceuticals Opioid Use Disorder Product
Table 75. Titan Pharmaceuticals Revenue in Opioid Use Disorder Business (2016-2021) & (US$ Million)
Table 76. Titan Pharmaceuticals Recent Development
Table 77. Hikma Pharmaceuticals Company Details
Table 78. Hikma Pharmaceuticals Business Overview
Table 79. Hikma Pharmaceuticals Opioid Use Disorder Product
Table 80. Hikma Pharmaceuticals Revenue in Opioid Use Disorder Business (2016-2021) & (US$ Million)
Table 81. Hikma Pharmaceuticals Recent Development
Table 82. Teva Pharmaceuticals Company Details
Table 83. Teva Pharmaceuticals Business Overview
Table 84. Teva Pharmaceuticals Opioid Use Disorder Product
Table 85. Teva Pharmaceuticals Revenue in Opioid Use Disorder Business (2016-2021) & (US$ Million)
Table 86. Teva Pharmaceuticals Recent Development
Table 87. MediciNova Company Details
Table 88. MediciNova Business Overview
Table 89. MediciNova Opioid Use Disorder Product
Table 90. MediciNova Revenue in Opioid Use Disorder Business (2016-2021) & (US$ Million)
Table 91. MediciNova Recent Development
Table 92. Orexo Company Details
Table 93. Orexo Business Overview
Table 94. Orexo Opioid Use Disorder Product
Table 95. Orexo Revenue in Opioid Use Disorder Business (2016-2021) & (US$ Million)
Table 96. Orexo Recent Development
Table 97. Camurus Company Details
Table 98. Camurus Business Overview
Table 99. Camurus Revenue in Opioid Use Disorder Business (2016-2021) & (US$ Million)
Table 100. Camurus Recent Development
Table 101. Omeros Company Details
Table 102. Omeros Business Overview
Table 103. Omeros Opioid Use Disorder Product
Table 104. Omeros Revenue in Opioid Use Disorder Business (2016-2021) & (US$ Million)
Table 105. Omeros Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Opioid Use Disorder Market Share by Type: 2020 VS 2027
Figure 2. Buprenorphine Features
Figure 3. Methadone Features
Figure 4. Naltrexone Features
Figure 5. Global Opioid Use Disorder Market Share by Application: 2020 VS 2027
Figure 6. Moderate Pain Treatment Case Studies
Figure 7. Severe Pain Treatment Case Studies
Figure 8. Opioid Use Disorder Report Years Considered
Figure 9. Global Opioid Use Disorder Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Opioid Use Disorder Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Opioid Use Disorder Market Share by Regions: 2020 VS 2027
Figure 12. Global Opioid Use Disorder Market Share by Regions (2022-2027)
Figure 13. Global Opioid Use Disorder Market Share by Players in 2020
Figure 14. Global Top Opioid Use Disorder Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid Use Disorder as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Opioid Use Disorder Revenue in 2020
Figure 16. Global Opioid Use Disorder Revenue Market Share by Type (2016-2021)
Figure 17. Global Opioid Use Disorder Revenue Market Share by Type (2022-2027)
Figure 18. North America Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Opioid Use Disorder Market Share by Type (2016-2027)
Figure 20. North America Opioid Use Disorder Market Share by Application (2016-2027)
Figure 21. North America Opioid Use Disorder Market Share by Country (2016-2027)
Figure 22. United States Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Opioid Use Disorder Market Share by Type (2016-2027)
Figure 26. Europe Opioid Use Disorder Market Share by Application (2016-2027)
Figure 27. Europe Opioid Use Disorder Market Share by Country (2016-2027)
Figure 28. Germany Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Opioid Use Disorder Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Opioid Use Disorder Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Opioid Use Disorder Market Share by Region (2016-2027)
Figure 38. China Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Opioid Use Disorder Market Share by Type (2016-2027)
Figure 46. Latin America Opioid Use Disorder Market Share by Application (2016-2027)
Figure 47. Latin America Opioid Use Disorder Market Share by Country (2016-2027)
Figure 48. Mexico Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Opioid Use Disorder Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Opioid Use Disorder Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Opioid Use Disorder Market Share by Country (2016-2027)
Figure 54. Turkey Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Indivior Revenue Growth Rate in Opioid Use Disorder Business (2016-2021)
Figure 58. Alkermes Revenue Growth Rate in Opioid Use Disorder Business (2016-2021)
Figure 59. Titan Pharmaceuticals Revenue Growth Rate in Opioid Use Disorder Business (2016-2021)
Figure 60. Hikma Pharmaceuticals Revenue Growth Rate in Opioid Use Disorder Business (2016-2021)
Figure 61. Teva Pharmaceuticals Revenue Growth Rate in Opioid Use Disorder Business (2016-2021)
Figure 62. MediciNova Revenue Growth Rate in Opioid Use Disorder Business (2016-2021)
Figure 63. Orexo Revenue Growth Rate in Opioid Use Disorder Business (2016-2021)
Figure 64. Camurus Revenue Growth Rate in Opioid Use Disorder Business (2016-2021)
Figure 65. Omeros Revenue Growth Rate in Opioid Use Disorder Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

以下、関連資料のご紹介

世界のオピオイド薬市場規模・現状・予測（2021年-2027年）

Global Opioid Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5910 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、オピオイド薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ブプレノルフィン、フェンタニル、ヒドロコドン、モルヒネ、オキシコドン、トラマドール、その他）、用途別市場規模（麻酔、鎮痛、咳抑制、下痢抑制、...

世界のオピオイド誘発性副作用治療市場規模・現状・予測（2021年-2027年）

Global Opioid Induced Side Effects Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5911 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、オピオイド誘発性副作用治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（リスペリドン、メチルフェニデート、セチリジン、その他）、用途別市場規模（薬物過剰摂取治療、疼痛治療、その他）、主要地域別市場規...

世界の非オピオイド疼痛治療市場規模・現状・予測（2021年-2027年）

Global Non-Opioid Pain Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5894 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、非オピオイド疼痛治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医療大麻治療、カプサイシン由来治療、メントール含有治療、オメガ3脂肪酸含有治療、ボツリヌス毒素）、用途別市場規模（整形外科・筋骨格痛...

世界のCDKL5欠乏症（CDD）市場規模・現状・予測（2021年-2027年）

Global CDKL5 Deficiency Disorder (CDD) Market Size, Status and Forecast 2021-2027
QFJ1-3983 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、CDKL5欠乏症（CDD）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（従来型医薬品、新型医薬品）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中...

世界のオピオイド離脱治療市場規模・現状・予測（2021年-2027年）

Global Opioid Withdrawal Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4618 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、オピオイド離脱治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗炎症薬、吐き気止め薬、鎮痛薬、その他）、用途別市場規模（病院薬局、小売薬局、オンラインストア）、主要地域別市場規模（北米、アメリカ、...

世界の網膜障害治療市場規模・現状・予測（2021年-2027年）

Global Retinal Disorder Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4826 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、網膜障害治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ジェル、カプセル＆錠剤、点眼薬、軟膏）、用途別市場規模（病院薬局、オンライン薬局、小売薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界の心的外傷後ストレス障害治療市場規模・現状・予測（2021年-2027年）

Global Post-Traumatic Stress Disorder Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4739 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、心的外傷後ストレス障害治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗うつ薬、抗不安薬、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界の心的外傷後ストレス障害治療薬市場規模・現状・予測（2021年-2027年）

Global Post-Traumatic Stress Disorder Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4738 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、心的外傷後ストレス障害治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗うつ薬、抗不安薬、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界の性欲低下障害（HSDD）治療市場規模・現状・予測（2021年-2027年）

Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4340 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、性欲低下障害（HSDD）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ブスピロン、ブプロピオン、テストステロン、フリバンセリン、ブレメラノチド、認知行動療法）、用途別市場規模（病院、診療所、その...

世界の糖尿病性神経障害治療薬市場規模・現状・予測（2021年-2027年）

Global Diabetic Neurological Disorder Therapeutic Drug Market Size, Status and Forecast 2021-2027
QFJ1-4124 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、糖尿病性神経障害治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カプセル、ピル、その他）、用途別市場規模（対称性神経障害、焦点＆多巣性神経障害）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

世界の非オピオイド疼痛治療市場規模・現状・予測（2021年-2027年） Non-Opioid Pain Treatment address acute and chronic pain and regulatory issues faced by healthcare professionals. With growing concerns about the addictive nature of opioid painkillers, more and more companies are working to develop effective but not addictive therapies. The interest and demand for …
世界のオピオイド誘発性副作用治療市場規模・現状・予測（2021年-2027年） Opioids are the class of drug that include strong pain relievers and illegal drugs such as heroin and illicit pain relievers for example hydrocodone, oxycodone, morphine and fentanyl. Also they are available legally on prescription. These drugs interact with opioid receptors on nerve cells in body a…
世界のオピオイド離脱治療市場規模・現状・予測（2021年-2027年） In some cases, usage of opioids causes addiction, and opioid withdrawal syndrome is a life-threatening condition resulting from opioid dependence. These drugs can also cause severe health problems and sometimes even result in overdose and loss of life. Hence this opioid dependence requires treatment…
世界のオピオイド薬市場規模・現状・予測（2021年-2027年） Opioid Drugs can act on the pain central system in the human brain, brainstem and other tissues, thus exerting a strong downward pain suppression effect. Opioid Drugs can not only bind to peripheral nerve opioid receptors, but also to opioid receptors in the gelatinous (second layer) sensory neurons…
世界の物質使用障害治療市場規模・現状・予測（2021年-2027年） Drug addiction, also called substance use disorder, is a disease that affects a person's brain and behavior and leads to an inability to control the use of a legal or illegal drug or medication. Substances such as alcohol, marijuana and nicotine also are considered drugs. Market Analysis and Insight…